Lifeboat Foundation

It’s too early to call it a miracle cure, but if the conclusions from a recent Phase 1 trial for a new drug called EXO-C24 are backed up in subsequent trials, we might have the first true breakthrough therapy for COVID-19. That’s in addition to coronavirus vaccines, of course, which will help prevent severe COVID-19 cases and deaths, and even reduce the spread of the illness. But while vaccines can give the immune system a heads-up to the threat it might have to deal with — the real virus — they have a few limitations. First of all, they don’t work on infected people. Secondly, vaccine supply is still limited and vaccinations aren’t available to anybody who might want one. Then there’s the threat of coronavirus mutations that might reduce vaccines’ effect on the virus and extend the pandemic.

O,.o.

As the opioid epidemic raged on with an even greater force during COVID-19, the Scripps Research laboratory of chemist Kim Janda, Ph.D., has been working on new therapeutic interventions that may be able to prevent the bulk of deaths from opioid overdose.

Summary: A new AI system is not only able to analyze potential new variants of COVID-19, it can also vaccine design cycles within minutes, researchers report.

Source: USC

It can keep blood pumping for years while patients with heart failure wait for donor organs.

The European Commission has approved the sale of Carmat’s total artificial heart, which is designed for patients with end-stage heart failure.

Virtual reality isn’t just for gaming. Researchers can use virtual reality, or VR, to assess participants’ attention, memory and problem-solving abilities in real world settings. By using VR technology to examine how folks complete daily tasks, like making a grocery list, researchers can better help clinical populations that struggle with executive functioning to manage their everyday lives.

The ‘second wave’ of the coronavirus pandemic has resulted in much blame placed on a lack of appropriate safety measures. However, due to the impacts of weather, research suggests two outbreaks per year during a pandemic are inevitable.

At 2 a.m. one night last April, Michael Schoof triple-checked the numbers on his screen, took a deep breath, and fired off an email he’d been waiting all day to send.

A lanky species of wild rice turns compact and docile in a jiffy.

Possibly this will make covid-19 less severe and manageable.

Medicine developed at Ichilov moderates immune response, helps prevent deadly cytokine storm, researchers say; 29 of 30 phase 1 trial patients left hospital within 3–5 days.